TECH

Bio-Techne Corporation NASDAQ

Healthcare ·Biotechnology ·US · bio-techne.com

$54.74

Mkt Cap $8.6B

52w Low $46.05 33.3% of range 52w High $72.16

50d MA $54.75 200d MA $58.13

P/E (TTM) 117.1x

EV/EBITDA 38.7x

P/B 4.5x

Debt/Equity 0.2x

ROE 3.8%

P/FCF 31.6x

RSI (14) —

ATR (14) —

Beta 1.49

50d MA $54.75

200d MA $58.13

Avg Volume 2.3M

About

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life sci…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Feb 4, 2026	AMC	0.43	0.46	+7.0%	68.67	-0.9%	-4.1%	-2.8%	-4.6%	-5.6%	-7.6%	—
Nov 5, 2025	AMC	0.42	0.42	-0.3%	59.94	+0.8%	-2.9%	-4.2%	-4.1%	-1.3%	+2.4%	—
Aug 6, 2025	AMC	0.50	0.53	+6.1%	49.87	+1.3%	+0.6%	+1.1%	+0.6%	+5.9%	+9.7%	—
May 7, 2025	AMC	0.51	0.56	+10.2%	48.75	-0.3%	+2.1%	+2.4%	+10.6%	+5.9%	-1.8%	—
Feb 5, 2025	AMC	0.39	0.42	+8.8%	75.25	+2.4%	-0.3%	-3.2%	-7.1%	-9.2%	-10.4%	—
Oct 30, 2024	AMC	0.38	0.42	+10.5%	76.02	-0.2%	-3.0%	-0.9%	-0.2%	+2.1%	-0.2%	—
Aug 7, 2024	AMC	0.49	0.49	-1.0%	70.96	+1.3%	+3.4%	+1.1%	+1.2%	+3.5%	+2.5%	—
May 1, 2024	AMC	0.45	0.48	+6.0%	73.46	+1.3%	+2.9%	+5.2%	+3.5%	+5.4%	+4.9%	—
Feb 1, 2024	AMC	0.41	0.40	-3.0%	68.54	-2.7%	-3.7%	-2.6%	-1.7%	-3.2%	-0.8%	—
Oct 31, 2023	AMC	0.44	0.41	-6.8%	54.63	+0.5%	-3.3%	+1.4%	+7.5%	+7.4%	+9.1%	—
Aug 8, 2023	AMC	0.55	0.55	+0.0%	84.30	-0.1%	-1.5%	-1.5%	+0.1%	+0.6%	+0.4%	—
May 3, 2023	AMC	0.53	0.53	+0.0%	85.98	-0.2%	-2.3%	-3.3%	-4.3%	-5.7%	-5.6%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 6	Evercore ISI	Maintains	In Line → In Line	—	$53.13	$53.13	+0.0%	+1.3%	+1.3%	+3.9%	+4.6%	+4.5%
Feb 6	Wells Fargo	Maintains	Overweight → Overweight	—	$65.86	$66.76	+1.4%	+1.4%	-0.6%	-1.6%	-3.7%	-9.6%
Feb 5	UBS	Maintains	Buy → Buy	—	$68.67	$68.04	-0.9%	-4.1%	-2.8%	-4.6%	-5.6%	-7.6%
Feb 5	TD Cowen	Maintains	Buy → Buy	—	$68.67	$68.04	-0.9%	-4.1%	-2.8%	-4.6%	-5.6%	-7.6%
Feb 5	Evercore ISI	Maintains	In Line → In Line	—	$68.67	$68.04	-0.9%	-4.1%	-2.8%	-4.6%	-5.6%	-7.6%
Feb 5	Stifel	Maintains	Hold → Hold	—	$68.67	$68.04	-0.9%	-4.1%	-2.8%	-4.6%	-5.6%	-7.6%
Feb 5	Citigroup	Maintains	Buy → Buy	—	$68.67	$68.04	-0.9%	-4.1%	-2.8%	-4.6%	-5.6%	-7.6%
Jan 5	Evercore ISI	Downgrade	Outperform → In Line	—	$59.65	$59.05	-1.0%	+5.7%	+9.4%	+9.1%	+8.3%	+10.1%
Nov 20	Argus	Maintains	Buy → Buy	—	$57.81	$59.10	+2.2%	+1.6%	+6.4%	+9.8%	+13.9%	+11.8%
Nov 6	Wells Fargo	Maintains	Overweight → Overweight	—	$59.94	$60.43	+0.8%	-2.9%	-4.2%	-4.1%	-1.3%	+2.4%
Nov 6	UBS	Maintains	Buy → Buy	—	$59.94	$60.43	+0.8%	-2.9%	-4.2%	-4.1%	-1.3%	+2.4%
Oct 14	TD Cowen	Maintains	Buy → Buy	—	$59.65	$58.73	-1.5%	-0.6%	-0.1%	+3.3%	+3.7%	+4.8%
Oct 7	Evercore ISI	Maintains	Outperform → Outperform	—	$61.92	$62.10	+0.3%	-4.4%	-2.2%	-3.3%	-5.3%	-3.7%
Sep 3	RBC Capital	Upgrade	Sector Perform → Outperform	—	$53.42	$53.60	+0.3%	-0.1%	-0.9%	+1.9%	+1.3%	+1.5%
Aug 21	Citigroup	Upgrade	Neutral → Buy	—	$54.33	$54.66	+0.6%	-0.6%	+5.1%	+4.4%	+4.5%	+3.5%
Aug 7	RBC Capital	Maintains	Sector Perform → Sector Perform	—	$49.87	$50.51	+1.3%	+0.6%	+1.1%	+0.6%	+5.9%	+9.7%
Jul 11	Scotiabank	Maintains	Sector Outperform → Sector Outperform	—	$54.41	$53.68	-1.3%	-0.5%	-3.3%	-5.5%	-4.8%	-2.1%
Jun 5	Benchmark	Maintains	Buy → Buy	—	$49.85	$49.80	-0.1%	-3.1%	-2.3%	+0.1%	+3.1%	+3.4%
May 9	UBS	Maintains	Buy → Buy	—	$49.78	$50.00	+0.4%	+0.3%	+8.3%	+3.7%	-3.9%	-3.1%
May 8	RBC Capital	Maintains	Sector Perform → Sector Perform	—	$48.75	$48.59	-0.3%	+2.1%	+2.4%	+10.6%	+5.9%	-1.8%
May 8	Benchmark	Maintains	Buy → Buy	—	$48.75	$48.59	-0.3%	+2.1%	+2.4%	+10.6%	+5.9%	-1.8%
May 8	Stifel	Maintains	Hold → Hold	—	$48.75	$48.59	-0.3%	+2.1%	+2.4%	+10.6%	+5.9%	-1.8%
Apr 9	KeyBanc Capital Markets	Downgrade	Overweight → Sector Weight	—	$48.81	$46.53	-4.7%	+10.8%	+0.9%	+3.9%	+7.6%	+4.6%
Apr 8	KeyBanc Capital Markets	Downgrade	Overweight → Sector Weight	—	$52.31	$53.26	+1.8%	-6.7%	+3.4%	-5.8%	-3.0%	+0.4%
Mar 4	Citigroup	Maintains	Neutral → Neutral	—	$61.19	$60.70	-0.8%	-1.7%	+1.7%	+3.6%	+5.2%	+2.8%
Feb 19	Baird	Downgrade	Outperform → Neutral	—	$65.29	$63.52	-2.7%	+0.8%	+0.3%	-0.6%	+0.4%	-1.6%
Feb 6	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$75.25	$77.03	+2.4%	-0.3%	-3.2%	-7.1%	-9.2%	-10.4%
Feb 6	RBC Capital	Maintains	Sector Perform → Sector Perform	—	$75.25	$77.03	+2.4%	-0.3%	-3.2%	-7.1%	-9.2%	-10.4%
Feb 6	Baird	Maintains	Outperform → Outperform	—	$75.25	$77.03	+2.4%	-0.3%	-3.2%	-7.1%	-9.2%	-10.4%
Feb 6	Scotiabank	Maintains	Sector Outperform → Sector Outperform	—	$75.25	$77.03	+2.4%	-0.3%	-3.2%	-7.1%	-9.2%	-10.4%
Oct 31	Baird	Maintains	Outperform → Outperform	—	$76.02	$75.89	-0.2%	-3.0%	-0.9%	-0.2%	+2.1%	-0.2%
Oct 31	Scotiabank	Maintains	Sector Outperform → Sector Outperform	—	$76.02	$75.89	-0.2%	-3.0%	-0.9%	-0.2%	+2.1%	-0.2%
Aug 13	Benchmark	Maintains	Buy → Buy	—	$71.78	$71.65	-0.2%	+2.3%	+1.4%	+4.4%	+3.8%	+4.5%
Aug 8	RBC Capital	Maintains	Sector Perform → Sector Perform	—	$70.96	$71.90	+1.3%	+3.4%	+1.1%	+1.2%	+3.5%	+2.5%
Aug 8	Baird	Maintains	Outperform → Outperform	—	$70.96	$71.90	+1.3%	+3.4%	+1.1%	+1.2%	+3.5%	+2.5%
May 22	Citigroup	Downgrade	Buy → Neutral	—	$82.68	$80.97	-2.1%	+0.4%	-2.7%	-2.3%	-4.0%	-4.9%
May 2	Baird	Maintains	Outperform → Outperform	—	$73.46	$74.45	+1.3%	+2.9%	+5.2%	+3.5%	+5.4%	+4.9%
May 2	Benchmark	Maintains	Buy → Buy	—	$73.46	$74.45	+1.3%	+2.9%	+5.2%	+3.5%	+5.4%	+4.9%
Apr 18	Deutsche Bank	Maintains	Buy → Buy	—	$62.73	$61.61	-1.8%	-0.8%	-1.0%	+0.1%	+1.5%	+1.3%
Feb 2	RBC Capital	Maintains	Sector Perform → Sector Perform	—	$68.54	$66.68	-2.7%	-3.7%	-2.6%	-1.7%	-3.2%	-0.8%
Feb 2	Stifel	Downgrade	Buy → Hold	—	$68.54	$66.68	-2.7%	-3.7%	-2.6%	-1.7%	-3.2%	-0.8%
Feb 2	Stephens & Co.	Maintains	Overweight → Overweight	—	$68.54	$66.68	-2.7%	-3.7%	-2.6%	-1.7%	-3.2%	-0.8%
Nov 2	Stifel	Maintains	Buy → Buy	—	$52.83	$53.77	+1.8%	+4.9%	+11.1%	+11.1%	+12.9%	+11.1%
Nov 1	Citigroup	Maintains	Buy → Buy	—	$54.63	$54.93	+0.5%	-3.3%	+1.4%	+7.5%	+7.4%	+9.1%
Nov 1	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$54.63	$54.93	+0.5%	-3.3%	+1.4%	+7.5%	+7.4%	+9.1%
Nov 1	RBC Capital	Maintains	Sector Perform → Sector Perform	—	$54.63	$54.93	+0.5%	-3.3%	+1.4%	+7.5%	+7.4%	+9.1%
Sep 12	RBC Capital	Maintains	Sector Perform → Sector Perform	—	$71.63	$71.21	-0.6%	+0.5%	+1.2%	+3.4%	+2.8%	-0.6%
Aug 18	Benchmark	Maintains	Buy → Buy	—	$80.24	$79.59	-0.8%	-2.5%	-1.9%	-2.5%	-1.9%	-1.8%
Aug 9	Stephens & Co.	Maintains	Overweight → Overweight	—	$84.30	$84.20	-0.1%	-1.5%	-1.5%	+0.1%	+0.6%	+0.4%
May 4	Stephens & Co.	Maintains	Overweight → Overweight	—	$85.98	$85.83	-0.2%	-2.3%	-3.3%	-4.3%	-5.7%	-5.6%

Recent Filings

8-K · 5.02 !!! Very High

Bio-Techne Corp. -- 8-K 5.02: Executive Change

Bio-Techne's Diagnostics and Spatial Biology segment President Matt McManus is departing March 1, 2026, though he'll remain temporarily to ensure transition continuity.

Feb 11

8-K · 8.01 !! High

Bio-Techne Corp. -- 8-K 8.01: Material Event / Announcement

Bio-Techne Corporation announced a cash dividend, signaling confidence in its financial position and returning capital to shareholders.

Feb 4

Data updated apr 27, 2026 4:22am · Source: massive.com